Suchergebnisse - "rucaparib"

PubPharm (68)

1

PARP inhibitor era in ovarian cancer treatment : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Journal of ovarian research | 2024

von Baradács, I. | Teutsch, B. | Váradi, A. | +9

2

Personalized medicine for metastatic prostate cancer : The paradigm of PARP inhibitors

enthalten in: Critical reviews in oncology/hematology | 2023

von Maiorano, B. | Conteduca, V. | Catalano, M. | +4

3

Real-World Efficacy and Safety of PARP Inhibitors in Recurrent Ovarian Cancer Patients With Somatic BRCA and Other Homologous Recombination Gene Mutations

enthalten in: The Annals of pharmacotherapy | 2023

von Pan, Y. | Hood, A. | Ahmad, H. | +1

4

A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients

enthalten in: Journal of pharmacy practice | 2023

von Lee, C. | Hernandez, J. | Liang, C. | +4

5

A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Pook, D. | Geynisman, D. | Carles, J. | +18

6

Rucaparib or Physician's Choice in Metastatic Prostate Cancer

enthalten in: The New England journal of medicine | 2023

von Fizazi, K. | Piulats, J. | Reaume, M. | +126

CommentIn: Nat Rev Urol. 2023 Apr;20(4):199. - PMID 36928618

7

Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma

enthalten in: Gynecologic oncology | 2022

von O'Malley, D. | Oza, A. | Lorusso, D. | +19

CommentIn: Gynecol Oncol. 2023 Apr;171:162-163. - PMID 36528399

8

Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib

enthalten in: Clinical pharmacokinetics | 2022

von Liao, M. | Beltman, J. | Giordano, H. | +4

9

Rucaparib in recurrent ovarian cancer : real-world experience from the rucaparib early access programme in Spain - A GEICO study

enthalten in: BMC cancer | 2022

von Yubero, A. | Barquín, A. | Estévez, P. | +21

10

Imaging PARP with [18F]rucaparib in pancreatic cancer models

enthalten in: European journal of nuclear medicine and molecular imaging | 2022

von Chan, C. | Chen, Z. | Destro, G. | +9

CommentIn: Radiol Imaging Cancer. 2022 Sep;4(5):e229018. - PMID 36112035

1
2
3
4
5
6
7
Nächster »
[7]